Volz TJ[au] - Search Results

Year	Number of Results
2001	1
2002	1
2004	2
2005	3
2006	3
2007	5
2008	6
2009	5
2014	1
2017	1
2022	0

1

New insights into the mechanism of action of amphetamines.

Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. Fleckenstein AE, et al. Among authors: volz tj. Annu Rev Pharmacol Toxicol. 2007;47:681-98. doi: 10.1146/annurev.pharmtox.47.120505.105140. Annu Rev Pharmacol Toxicol. 2007. PMID: 17209801 Review.

2

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic deficits.

Volz TJ, Hanson GR, Fleckenstein AE. Volz TJ, et al. J Neurochem. 2007 May;101(4):883-8. doi: 10.1111/j.1471-4159.2006.04419.x. Epub 2007 Jan 23. J Neurochem. 2007. PMID: 17250674 Free article. Review.

3

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Fleckenstein AE, Volz TJ, Hanson GR. Fleckenstein AE, et al. Among authors: volz tj. Neuropharmacology. 2009;56 Suppl 1(Suppl 1):133-8. doi: 10.1016/j.neuropharm.2008.07.002. Epub 2008 Jul 10. Neuropharmacology. 2009. PMID: 18662707 Free PMC article. Review.

4

Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.

Volz TJ, Fleckenstein AE, Hanson GR. Volz TJ, et al. Addiction. 2007 Apr;102 Suppl 1:44-8. doi: 10.1111/j.1360-0443.2007.01771.x. Addiction. 2007. PMID: 17493052 Review.

5

A comprehensive atlas of the topography of functional groups of the dopamine transporter.

Volz TJ, Schenk JO. Volz TJ, et al. Synapse. 2005 Nov;58(2):72-94. doi: 10.1002/syn.20183. Synapse. 2005. PMID: 16088952 Review.

6

Transformation of shock-compressed graphite to hexagonal diamond in nanoseconds.

Turneaure SJ, Sharma SM, Volz TJ, Winey JM, Gupta YM. Turneaure SJ, et al. Among authors: volz tj. Sci Adv. 2017 Oct 27;3(10):eaao3561. doi: 10.1126/sciadv.aao3561. eCollection 2017 Oct. Sci Adv. 2017. PMID: 29098183 Free PMC article.

7

Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.

Volz TJ, Farnsworth SJ, Hanson GR, Fleckenstein AE. Volz TJ, et al. Ann N Y Acad Sci. 2008 Oct;1139:285-90. doi: 10.1196/annals.1432.012. Ann N Y Acad Sci. 2008. PMID: 18991873 Free PMC article.

8

Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake.

Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ 2nd, Adair BP, Bitter R, Gibb JW, Hanson GR, Fleckenstein AE. Rau KS, et al. Among authors: volz tj. J Pharmacol Exp Ther. 2006 Aug;318(2):676-82. doi: 10.1124/jpet.105.099200. Epub 2006 May 10. J Pharmacol Exp Ther. 2006. PMID: 16687477

9

Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Volz TJ. Volz TJ. Curr Neuropharmacol. 2008 Dec;6(4):379-85. doi: 10.2174/157015908787386041. Curr Neuropharmacol. 2008. PMID: 19587858 Free PMC article.

10

Kinetic analysis of developmental changes in vesicular monoamine transporter-2 function.

Volz TJ, Hanson GR, Fleckenstein AE. Volz TJ, et al. Synapse. 2006 Nov;60(6):474-7. doi: 10.1002/syn.20321. Synapse. 2006. PMID: 16897727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results